These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 18260176

  • 1. The risk of hospitalized infection in patients with rheumatoid arthritis.
    Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA.
    J Rheumatol; 2008 Mar; 35(3):387-93. PubMed ID: 18260176
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis.
    Bernatsky S, Hudson M, Suissa S.
    Rheumatology (Oxford); 2005 May; 44(5):677-80. PubMed ID: 15784627
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H, Nicola PJ, Crowson CS, O'Fallon WM, Gabriel SE.
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [Abstract] [Full Text] [Related]

  • 6. Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada.
    Brassard P, Lowe AM, Bernatsky S, Kezouh A, Suissa S.
    Arthritis Rheum; 2009 Mar 15; 61(3):300-4. PubMed ID: 19248128
    [Abstract] [Full Text] [Related]

  • 7. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S.
    Arthritis Rheum; 2006 Dec 15; 54(12):3790-8. PubMed ID: 17136752
    [Abstract] [Full Text] [Related]

  • 8. Antirheumatic drugs and the risk of tuberculosis.
    Brassard P, Kezouh A, Suissa S.
    Clin Infect Dis; 2006 Sep 15; 43(6):717-22. PubMed ID: 16912945
    [Abstract] [Full Text] [Related]

  • 9. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.
    Suissa S, Hudson M, Ernst P.
    Arthritis Rheum; 2006 May 15; 54(5):1435-9. PubMed ID: 16645972
    [Abstract] [Full Text] [Related]

  • 10. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis.
    Wolfe F, Michaud K.
    Arthritis Rheum; 2008 Sep 15; 58(9):2612-21. PubMed ID: 18759273
    [Abstract] [Full Text] [Related]

  • 11. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
    Malysheva OA, Wahle M, Wagner U, Pierer M, Arnold S, Häntzschel H, Baerwald CG.
    J Rheumatol; 2008 Jun 15; 35(6):979-85. PubMed ID: 18412314
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
    Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE.
    Arthritis Rheum; 2005 Feb 15; 52(2):402-11. PubMed ID: 15693010
    [Abstract] [Full Text] [Related]

  • 14. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis.
    Bernatsky S, Hudson M, Suissa S.
    Rheumatology (Oxford); 2007 Jul 15; 46(7):1157-60. PubMed ID: 17478469
    [Abstract] [Full Text] [Related]

  • 15. No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.
    van den Borne BE, Landewé RB, Houkes I, Schild F, van der Heyden PC, Hazes JM, Vandenbroucke JP, Zwinderman AH, Goei The HS, Breedveld FC, Bernelot Moens HJ, Kluin PM, Dijkmans BA.
    Arthritis Rheum; 1998 Nov 15; 41(11):1930-7. PubMed ID: 9811046
    [Abstract] [Full Text] [Related]

  • 16. Patterns of drug use in rheumatoid arthritis.
    Bérard A, Solomon DH, Avorn J.
    J Rheumatol; 2000 Jul 15; 27(7):1648-55. PubMed ID: 10914846
    [Abstract] [Full Text] [Related]

  • 17. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
    van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE.
    Arthritis Res Ther; 2006 Jul 15; 8(5):R151. PubMed ID: 16984661
    [Abstract] [Full Text] [Related]

  • 18. Predictors of infection in rheumatoid arthritis.
    Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE.
    Arthritis Rheum; 2002 Sep 15; 46(9):2294-300. PubMed ID: 12355476
    [Abstract] [Full Text] [Related]

  • 19. Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study.
    Hellgren K, Iliadou A, Rosenquist R, Feltelius N, Backlin C, Enblad G, Askling J, Baecklund E.
    Ann Rheum Dis; 2010 Apr 15; 69(4):654-9. PubMed ID: 19439429
    [Abstract] [Full Text] [Related]

  • 20. Current tumor necrosis factor-alpha inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis.
    Liang GC, Cordero M, Dyer A, Chang RW.
    J Rheumatol; 2005 Sep 15; 32(9):1662-5. PubMed ID: 16142857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.